REGISTERED
on 18 Jun 2024
Last Applicant/ Owned by
North Ryde NSW 2113
AU
Serial Number
79368307 filed on 13th Dec 2022
Registration Number
7416497 registered on 18th Jun 2024
Correspondent Address
Timothy J. Kelly
Filing Basis
1. filing basis filed as 66 a
Disclaimer
NO DATA
BIOSCEPTRE
Analysis of biological samples; biopharmaceutical and pharmaceutical development and research and evaluation services in the field of cell based therapeutics and gene therapy for the treatment of disease, injuries and disorders; biotechnology laboratory services; medical and scientific laboratory services; scientific, medical and clinical research consultation services and scientific, medical and Read More
Classification Information
Class [042]
Computer & Software Services & Scientific Services
Analysis of biological samples; biopharmaceutical and pharmaceutical development and research and evaluation services in the field of cell based therapeutics and gene therapy for the treatment of disease, injuries and disorders; biotechnology laboratory services; medical and scientific laboratory services; scientific, medical and clinical research consultation services and scientific, medical and clinical research and development services, including in the field of hematology, immunology, cancer research, developmental biology and life sciences, biotechnology, medical technology, cell culture, tissue engineering, genetic engineering, regenerative medicine, immunotherapy and immunomodulation; medical and scientific research, namely, conducting pre-clinical and clinical trials for others; pharmaceutical, medical, scientific, biotechnology, and biopharmaceutical research and development; technical scientific consultation and product development for others in the field of biotechnology and immunology; development of pharmaceuticals; research and development in the field of computational biology, bioinformatics, and genomics; providing medical and scientific research information in the field of pharmaceuticals and clinical trials; research and development of pharmaceutical preparations and substances for use in clinical trials; chemical analysis; industrial design; conducting technical project studies in the fields of medicine, biotechnology, therapeutics, pharmaceuticals, biopharmaceuticals, biotherapeutics, radiology, cardiology, oncology, epidemiology, pulmonology, neurology, hematology, endocrinology, otolaryngology, gastroenterology, nephrology, gynecology, obstetrics, urology, orthopedics, ophthalmology, pathology, pediatrics, surgery, medical genetics, medical genomics, dermatology, immunology, and preventive medicine; research and development of new products for others; material testing; biological research; scientific laboratory services; scientific research; bacteriological research
First Use Date in General
N/A
First Use Date in Commerce
N/A
Class [005]
Pharmaceutical Products
Biopharmaceutical and pharmaceutical preparations for treatment of autoimmune diseases, cancer, cardiovascular diseases and disorders, endocrine diseases and disorders, gastrointestinal diseases and disorders, infectious diseases, psychiatric and psychological diseases and disorders, neurological diseases and disorders, and respiratory diseases and disorders; therapeutic agents for the treatment of autoimmune diseases, cancer, cardiovascular diseases and disorders, endocrine diseases and disorders, gastrointestinal diseases and disorders, infectious diseases, psychiatric and psychological diseases and disorders, neurological diseases and disorders, and respiratory diseases and disorders; veterinary preparations, namely biopharmaceutical preparations for use in the treatment of autoimmune diseases, cancer, tumors, blood-related diseases, inflammation, cardiovascular diseases and disorders, endocrine diseases and disorders, gastrointestinal diseases and disorders, infectious diseases, psychiatric and psychological diseases and disorders, neurological diseases and disorders, and respiratory diseases and disorders; veterinary preparations, namely pharmaceutical preparations for use in the treatment of autoimmune diseases, cancer, tumors, blood-related diseases, inflammation, cardiovascular diseases and disorders, endocrine diseases and disorders, gastrointestinal diseases and disorders, infectious diseases, psychiatric and psychological diseases and disorders, neurological diseases and disorders, and respiratory diseases and disorders; biological preparations for veterinary purposes, namely biopharmaceutical preparations for use in the treatment of autoimmune diseases, cancer, tumors, blood-related diseases, inflammation, cardiovascular diseases and disorders, endocrine diseases and disorders, gastrointestinal diseases and disorders, infectious diseases, psychiatric and psychological diseases and disorders, neurological diseases and disorders, and respiratory diseases and disorders; biological preparations for veterinary purposes, namely pharmaceutical preparations for use in the treatment of autoimmune diseases, cancer, tumors, blood-related diseases, inflammation, cardiovascular diseases and disorders, endocrine diseases and disorders, gastrointestinal diseases and disorders, infectious diseases, psychiatric and psychological diseases and disorders, neurological diseases and disorders, and respiratory diseases and disorders; cultures of microorganisms for medical and veterinary use; biological preparations for medical purposes, namely biopharmaceutical preparations for use in the treatment of autoimmune diseases, cancer, tumors, blood-related diseases, inflammation, cardiovascular diseases and disorders, endocrine diseases and disorders, gastrointestinal diseases and disorders, infectious diseases, psychiatric and psychological diseases and disorders, neurological diseases and disorders, and respiratory diseases and disorders; biological preparations for medical purposes, namely pharmaceutical preparations for use in the treatment of autoimmune diseases, cancer, tumors, blood-related diseases, inflammation, cardiovascular diseases and disorders, endocrine diseases and disorders, gastrointestinal diseases and disorders, infectious diseases, psychiatric and psychological diseases and disorders, neurological diseases and disorders, and respiratory diseases and disorders; drugs for medical purposes, namely biopharmaceutical preparations for use in the treatment of autoimmune diseases, cancer, tumors, blood-related diseases, inflammation, cardiovascular diseases and disorders, endocrine diseases and disorders, gastrointestinal diseases and disorders, infectious diseases, psychiatric and psychological diseases and disorders, neurological diseases and disorders, and respiratory diseases and disorders; drugs for medical purposes, namely pharmaceutical preparations for use in the treatment of autoimmune diseases, cancer, tumors, blood-related diseases, inflammation, cardiovascular diseases and disorders, endocrine diseases and disorders, gastrointestinal diseases and disorders, infectious diseases, psychiatric and psychological diseases and disorders, neurological diseases and disorders, and respiratory diseases and disorders; diagnostic preparations for medical purposes; enzymes for medical purposes; biochemical medicines for use in the treatment of autoimmune diseases, cancer, tumors, blood-related diseases, inflammation, cardiovascular diseases and disorders, endocrine diseases and disorders, gastrointestinal diseases and disorders, infectious diseases, psychiatric and psychological diseases and disorders, neurological diseases and disorders, and respiratory diseases and disorders; vaccines; bioengineering pharmaceutical solutions for use in expanding cells for therapeutic use to patients with blood cancers and other diseases; biopharmaceuticals, namely biopharmaceutical products for use in the treatment of autoimmune diseases, cancer, tumors, blood-related diseases, inflammation, cardiovascular diseases and disorders, endocrine diseases and disorders, gastrointestinal diseases and disorders, infectious diseases, psychiatric and psychological diseases and disorders, neurological diseases and disorders, and respiratory diseases and disorders; cells and biological preparations, namely, blood, stem cells, adult blood cells, immune cells, immunomodulatory cells, umbilical cord cells, umbilical cord blood, and placental tissue intended for medical and clinical use, including, blood, stem cells, adult blood cells, immune cells, immunomodulatory cells, umbilical cord cells, umbilical cord blood, and placental tissue; bioengineered cells for use in immunotherapies; diagnostic substances and diagnostic preparations for medical purposes; gene and cell therapy and prophylaxis products, namely, therapeutic pharmaceuticals for use in the treatment of autoimmune diseases, cancer, tumors, blood-related diseases, inflammation, cardiovascular diseases and disorders, endocrine diseases and disorders, gastrointestinal diseases and disorders, infectious diseases, psychiatric and psychological diseases and disorders, neurological diseases and disorders, and respiratory diseases and disorders; gene and cell therapy prophylaxis vector preparations for therapeutic purposes for use in the treatment of autoimmune diseases, cancer, tumors, blood-related diseases, inflammation, cardiovascular diseases and disorders, endocrine diseases and disorders, gastrointestinal diseases and disorders, infectious diseases, psychiatric and psychological diseases and disorders, neurological diseases and disorders, and respiratory diseases and disorders; pharmaceutical preparations and products, namely pharmaceutical preparations and products for use in the treatment of autoimmune diseases, cancer, tumors, blood-related diseases, inflammation, cardiovascular diseases and disorders, endocrine diseases and disorders, gastrointestinal diseases and disorders, infectious diseases, psychiatric and psychological diseases and disorders, neurological diseases and disorders, and respiratory diseases and disorders; pharmaceutical preparations in the nature of cell solutions to enable cell expansion for therapeutic purposes; reagents for ex vivo cell processing in particular media suitable for the expansion of cells for therapeutic purposes; cell products for therapeutic purposes, namely stem and progenitor cell, adult cell, immune cell, cell therapy and gene therapy products; cells for medical purposes
First Use Date in General
N/A
First Use Date in Commerce
N/A
Mark Details
Serial Number
No 79368307
Mark Type
No Service Mark
Attorney Docket Number
No
44D Filed
No
44D Current
No
44E filed
No
44E Current
No
66A Filed
Yes
66A Current
Yes
Current Basis
No
No Basis
No
Legal History
| Status Date | Action Taken |
|---|---|
| 18th Sep 2024 | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB |
| 18th Jun 2024 | NOTICE OF REGISTRATION CONFIRMATION EMAILED |
| 18th Jun 2024 | REGISTERED-PRINCIPAL REGISTER |
| 16th Apr 2024 | NOTIFICATION PROCESSED BY IB |
| 02th Apr 2024 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| 02th Apr 2024 | PUBLISHED FOR OPPOSITION |
| 27th Mar 2024 | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB |
| 27th Mar 2024 | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB |
| 13th Mar 2024 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| 29th Feb 2024 | APPROVED FOR PUB - PRINCIPAL REGISTER |